Race/ethnicity affects the probability of finding an HLA-A, -B, -C and -DRB1 allele-matched unrelated donor and likelihood of subsequent transplant utilization
PIDALA, J, KIM, J, FERNANDEZ, H. F, FIELD, T, LOCKE, F. L, NISHIHORI, T, OCHOA, J. L, PEREZ, L, PERKINS, J, SHAPIRO, J, TATE, C, TOMBLYN, M, SCHELL, M, ANASETTI, C, LEE, S. J, HILLGRUBER, R, NYE, V, AYALA, E, ALSINA, M, BETTS, B, BOOKOUT, R
Published in Bone marrow transplantation (Basingstoke) (01.03.2013)
Published in Bone marrow transplantation (Basingstoke) (01.03.2013)
Get full text
Journal Article
Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML
LOCKE, F. L, ARTZ, A, RICH, E, ZHANG, Y, VAN BESIEN, K, STOCK, W
Published in Bone marrow transplantation (Basingstoke) (01.12.2010)
Published in Bone marrow transplantation (Basingstoke) (01.12.2010)
Get full text
Journal Article
Sirolimus, tacrolimus and antithymocyte globulin as GVHD prophylaxis in HLA-mismatched unrelated donor hematopoietic cell transplantation: a single institution experience
Nelson, R, Shapiro, J F, Perkins, J B, Kim, J, Nishihori, T, Pidala, J, Ayala, E, Locke, F L, Field, T, Mishra, A, Riches, M, Betts, B, Perez, L, Yue, B, Ochoa-Bayona, J L, Alsina, M, Fernandez, H, Anasetti, C, Kharfan-Dabaja, M A
Published in Bone marrow transplantation (Basingstoke) (01.11.2015)
Published in Bone marrow transplantation (Basingstoke) (01.11.2015)
Get full text
Journal Article
Real‐world outcomes of brexucabtagene autoleucel (brexu‐cel) for relapsed or refractory mantle cell lymphoma (r/r MCL): A CIBMTR subgroup analysis by prior treatment
Ahmed, N., Kambhampati, S., Hamadani, M., Grover, N., Shadman, M., Locke, F. L., Gerson, J., Frank, M. J., Budde, L. E., Wang, M., Hu, Z., Nunes, A., Dalton, D., Kloos, I., Lee, D., Xu, H., Pasquini, M., Herrera, A.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
DURABLES RESPONSES WITH ANTI‐CD19 ALLOGENEIC CAR T ALLO‐501/501A IN PHASE 1 TRIALS OF RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (R/R LBCL)
Locke, F. L., Lekakis, L., Eradat, H., Munoz, J., Tees, M., Vos, S., Nath, R., Stevens, D., Malik, S., Popplewell, L., Hamadani, M., Oluwole, O., Perales, M., Miklos, D., Fisher, P., Goyal, L., Navale, L., Kaufman, G., Kai, K., Balakumaran, A., Neelapu, S.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
PRIMARY OVERALL SURVIVAL ANALYSIS OF THE PHASE 3 RANDOMIZED ZUMA‐7 STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA
Westin, J. R., Oluwole, O. O., Kersten, M. J., Miklos, D. B., Perales, M.‐A., Ghobadi, A., Rapoport, A. P., Sureda, A., Jacobson, C. A., Farooq, U., Meerten, T., Ulrickson, M. L., Elsawy, M., Leslie, L. A., Chaganti, S., Dickinson, M., Yang, Y., Schupp, M., To, C., Locke, F. L.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
SEVERE HEMATOLOGICAL TOXICITY FOLLOWING CD19 CAR‐T FOR RELAPSED/REFRACTORY LBCL IS ASSOCIATED WITH SUPPRESSIVE IMMUNE DYSREGULATION AND LIMITED CAR‐T EXPANSION
Rejeski, K., Perez, A., Iacoboni, G., Blumenberg, V., Bücklein, V. L., Völkl, S., Penack, O., Albanyan, O., Petrera, A., Reid, K., Faramand, R., Davila, M. L., Bergwelt‐Baildon, M., Locke, F. L., Bethge, W., Bullinger, L., Mackensen, A., Barba, P., Jain, M. D., Subklewe, M.
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
P1117: THREE‐YEAR FOLLOW‐UP OF OUTCOMES WITH KTE‐X19 IN PATIENTS WITH RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA IN ZUMA‐2
Wang, M. L., Munoz, J., Goy, A., Locke, F. L., Jacobson, C. A., Hill, B. T., Timmerman, J. M., Holmes, H., Flinn, I. W., Miklos, D. B., Pagel, J. M., Kersten, M. J., Houot, R., Beitinjaneh, A., Peng, W., Fang, X., Shen, R. R., Siddiqi, R., Kloos, I., Reagan, P. M.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
P1198: ASSOCIATION OF PRETREATMENT TUMOR CHARACTERISTICS AND CLINICAL OUTCOMES FOLLOWING SECOND‐LINE AXICABTAGENE CILOLEUCEL VS STANDARD OF CARE IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA
Locke, F. L., Chou, J., Vardhanabhuti, S., Perbost, R., Dreger, P., Hill, B. T., Lee, C., Zinzani, P. L., Kröger, N., López‐Guillermo, A., Greinix, H., Zhang, W., Tiwari, G., To, C., Cheng, P., Bot, A., Shen, R., Filosto, S., Galon, J.
Published in HemaSphere (23.06.2022)
Published in HemaSphere (23.06.2022)
Get full text
Journal Article
S211: CLINICAL AND PATIENT‐REPORTED OUTCOMES IN A PHASE 3 STUDY OF AXICABTAGENE CILOLEUCEL (AXI‐CEL) VS STANDARD‐OF‐CARE IN ELDERLY PATIENTS WITH RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMA (ZUMA‐7)
Sureda, A., Westin, J., Locke, F. L., Dickinson, M., Ghobadi, A., Elsawy, M., Meerten, T., Miklos, D. B., Ulrickson, M., Perales, M.‐A., Farooq, U., Wannesson, L., Leslie, L., Kersten, M. J., Jacobson, C. A., Pagel, J. M., Wulf, G., Johnston, P., Rapoport, A. P., Gordon, L. I., Yang, Y., Peng, A., Du, L., Snider, J. T., Shah, J., Schupp, M., Cheng, P., To, C., Oluwole, O. O.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
Locke, Frederick L, Miklos, David B, Jacobson, Caron A, Perales, Miguel-Angel, Kersten, Marie-José, Oluwole, Olalekan O, Ghobadi, Armin, Rapoport, Aaron P, McGuirk, Joseph, Pagel, John M, Muñoz, Javier, Farooq, Umar, van Meerten, Tom, Reagan, Patrick M, Sureda, Anna, Flinn, Ian W, Vandenberghe, Peter, Song, Kevin W, Dickinson, Michael, Minnema, Monique C, Riedell, Peter A, Leslie, Lori A, Chaganti, Sridhar, Yang, Yin, Filosto, Simone, Shah, Jina, Schupp, Marco, To, Christina, Cheng, Paul, Gordon, Leo I, Westin, Jason R
Published in The New England journal of medicine (17.02.2022)
Published in The New England journal of medicine (17.02.2022)
Get full text
Journal Article
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Wang, Michael, Munoz, Javier, Goy, Andre, Locke, Frederick L, Jacobson, Caron A, Hill, Brian T, Timmerman, John M, Holmes, Houston, Jaglowski, Samantha, Flinn, Ian W, McSweeney, Peter A, Miklos, David B, Pagel, John M, Kersten, Marie-Jose, Milpied, Noel, Fung, Henry, Topp, Max S, Houot, Roch, Beitinjaneh, Amer, Peng, Weimin, Zheng, Lianqing, Rossi, John M, Jain, Rajul K, Rao, Arati V, Reagan, Patrick M
Published in The New England journal of medicine (02.04.2020)
Published in The New England journal of medicine (02.04.2020)
Get full text
Journal Article
Axicabtagene ciloleucel versus standard of care in second-line large B-cell lymphoma: outcomes by metabolic tumor volume
Locke, Frederick L, Oluwole, Olalekan O, Kuruvilla, John, Thieblemont, Catherine, Morschhauser, Franck, Salles, Gilles A., Rowe, Steven P., Vardhanabhuti, Saran, Winters, Joshua, Filosto, Simone, To, Christina, Cheng, Paul, Schupp, Marco, Korn, Ronald, Kersten, Marie José
Published in Blood (01.04.2024)
Published in Blood (01.04.2024)
Get full text
Journal Article
In-Field Failures in Patients Undergoing Bridging Radiotherapy for CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Recurrent/Refractory Large B-Cell Lymphomas
Sim, A.J., Figura, N.B., Dohm, A.E., Chavez, J.C., Shah, B.D., Khimani, F., Lazaryan, A., Davila, M.L., Bachmeier, C., Nishihori, T., Liu, H.D., Kim, S., Locke, F.L., Jain, M.D., Robinson, T.J.
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Published in International journal of radiation oncology, biology, physics (01.11.2021)
Get full text
Journal Article
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023
Locke, F L, Lekakis, L, Eradat, H, Munoz, J, Tees, M, de Vos, S, Nath, R, Stevens, D, Malik, S, Popplewell, L, Hamadani, M, Oluwole, O, Perales, M, Miklos, D, Fisher, P, Goyal, L, Navale, L, Kaufman, G, Kai, K, Balakumaran, A, Neelapu, S
Published in Hematological oncology (01.06.2023)
Published in Hematological oncology (01.06.2023)
Get full text
Journal Article
Merkel cell carcinoma and immunosuppression: what we still need to know
Locke, Frederick L, Rollison, Dana E, Sondak, Vernon K
Published in JNCI : Journal of the National Cancer Institute (01.02.2015)
Published in JNCI : Journal of the National Cancer Institute (01.02.2015)
Get full text
Journal Article
A randomized phase II study to evaluate tacrolimus in combination with sirolimus or methotrexate after allogeneic hematopoietic cell transplantation
PIDALA, Joseph, KIM, Jongphil, JANSSEN, William E, VEERAPATHRAN, Anandaraman, BETTS, Brian C, LOCKE, Frederick L, AYALA, Ernesto, FIELD, Teresa, OCHOA, Leonel, ALSINA, Melissa, ANASETTI, Claudio, JIM, Heather, KHARFAN-DABAJA, Mohamed A, NISHIHORI, Taiga, FERNANDEZ, Hugo F, TOMBLYN, Marcie, PEREZ, Lia, PERKINS, Janelle, MIAN XU
Published in Haematologica (Roma) (01.12.2012)
Published in Haematologica (Roma) (01.12.2012)
Get full text
Journal Article
ZUMA-2: A phase 2 multi-center study evaluating the efficacy of KTE-C19 (Anti-CD19 CAR T cells) in patients with relapsed/refractory Mantle cell lymphoma (R/R MCL)
Wang, M., Locke, F.L., Siddiqi, T., Castro, J., Shah, B., Lee, H., Budde, L.E., Choi, M., Anasetti, C., Champlin, R., Forman, S., Kipps, T., Bot, A., Rossi, J.M., Navale, L., Jiang, Y., Aycock, J., Elias, M., Wiezorek, J., Go, W.Y.
Published in Annals of oncology (01.10.2016)
Published in Annals of oncology (01.10.2016)
Get full text
Journal Article
Advice, Stories, and Myths: The Reactions of a Cliff Jumper
Locke, Lawrence F.
Published in Quest (National Association for Kinesiology in Higher Education) (01.05.1998)
Published in Quest (National Association for Kinesiology in Higher Education) (01.05.1998)
Get full text
Journal Article